Scholars@Duke

• Research
• 

  Selected Grants

  • Development of an oral targeted drug for treatment of bartonelloses awarded by Steven & Alexandra Cohen Foundation 2021 - 2025
  • Preclinical Development Of Novel Borrelia Sp. Targeting Therapeutic And Diagnostic Imaging Agents. awarded by Bay Area Lyme Foundation 2021 - 2023
  • Detection and Elimination of Oncogenic Signaling Networks in Pre-malignant and Malignant Cells with Magnetic Resonance Imaging awarded by Department of Defense 2012 - 2022
  • Improving the Oral Bioavailability and In vivo Efficacy of the TAK 1 Inhibitor, Takinib. awarded by Eydis Bio Inc. 2019 - 2021
  • An orally bioavailable broad-spectrum Hsp90 inhibitor (Hsp90i) therapy to suppress emerging Coronavirus (CoV) infections awarded by Good Ventures Foundation 2020 - 2021
• 

  External Relationships

  • Eydis Bio, Inc.
  • Innovasyn, LLC

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.